Apyx Medical Corporation (APYX)
NASDAQ: APYX · IEX Real-Time Price · USD
1.600
0.00 (0.00%)
At close: May 20, 2024, 4:00 PM
1.630
+0.030 (1.87%)
After-hours: May 20, 2024, 4:02 PM EDT
Apyx Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Apyx Medical stock have an average target of 6.17, with a low estimate of 4.50 and a high estimate of 9.00. The average target predicts an increase of 285.63% from the current stock price of 1.60.
Analyst Consensus: Buy
* Price targets were last updated on Nov 10, 2023.
Analyst Ratings
The average analyst rating for Apyx Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Maintains $8 → $5 | Buy | Maintains | $8 → $5 | +212.50% | Nov 10, 2023 |
Piper Sandler | Piper Sandler | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +181.25% | Aug 11, 2023 |
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +400.00% | Jul 14, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $6 → $9 | Strong Buy | Maintains | $6 → $9 | +462.50% | Jun 15, 2023 |
JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 24, 2023 |
Financial Forecast
Revenue This Year
50.94M
from 52.35M
Decreased by -2.70%
Revenue Next Year
55.61M
from 50.94M
Increased by 9.19%
EPS This Year
-0.79
from -0.54
EPS Next Year
-0.71
from -0.79
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 52.6M | 60.6M | 90.4M | 84.9M | 110.4M |
Avg | 50.9M | 55.6M | 72.3M | 81.9M | 101.7M |
Low | 48.7M | 52.4M | 57.7M | 78.2M | 92.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.5% | 18.9% | 62.5% | 17.4% | 34.7% |
Avg | -2.7% | 9.2% | 30.0% | 13.3% | 24.1% |
Low | -7.0% | 2.9% | 3.7% | 8.1% | 12.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.76 | -0.61 | -0.42 | -0.26 | -0.05 |
Avg | -0.79 | -0.71 | -0.49 | -0.26 | -0.05 |
Low | -0.89 | -0.87 | -0.56 | -0.25 | -0.05 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.